Remedy for diabetes

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9440980
APP PUB NO 20140309135A1
SERIAL NO

14261953

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method of screening a compound having a hypoglycemic effect (hereinafter referred to as “hypoglycemic compound”), a remedy for diabetes which contains a compound having a novel function mechanism, etc. More specifically speaking, a method of screening a hypoglycemic compound capable of binding to the β subunit of a trimeric GTP-binding protein, a remedy for diabetes comprising a hypoglycemic compound, which is characterized by being capable of binding to the β subunit of a trimeric GTP-binding protein, as the active ingredient, etc.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EA PHARMA CO LTD2-1-1 IRIFUNE CHUO-KU TOKYO 104-0042

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Arashida, Naoko Kawasaki, JP 12 8
Fukuchi, Naoyuki Kawasaki, JP 26 184
Fukuda, Yumiko Kawasaki, JP 6 18
Ikenoue, Takao Kawasaki, JP 10 67
Miyanaga, Wataru Kawasaki, JP 11 36
Okamoto, Satoru Kawasaki, JP 175 2019
Takayanagi, Masaru Kawasaki, JP 11 26
Takeshita, Sen Kawasaki, JP 13 69
Yamada, Naoyuki Kawasaki, JP 68 418

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 13, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00